Digoxin Toxicity, From Nausea to Bidirectional VT

A patient on digoxin who has quietly stopped eating is a cardiac concern until proven otherwise. The rhythm change hurts them. The appetite change shows up first, and that is usually what the stem hands you.

The gut complains before the heart does

StatPearls lists the earliest features of cardiac glycoside toxicity as gastrointestinal. Anorexia, nausea, and vomiting. Those often arrive before anything looks wrong on a monitor, which is exactly why they get explained away.

An older adult with no interest in dinner is easy to blame on the hospital tray. Nobody files a report about poor appetite. If that patient takes digoxin, the appetite is data rather than background noise.

Neurologic features sit alongside the gastrointestinal ones in the same source: headache, malaise, and altered mental status. In an older patient those get filed under aging, or under the admission diagnosis, or under a long day. Consider the drug first and rule outward from there.

The pattern worth reacting to is a cluster rather than a single symptom. Appetite, nausea, and a change in how somebody is thinking, arriving together over days, in a person taking a drug with very little room in it.

Single symptoms are noise. Clusters are signal.

Who the patient usually turns out to be

Digoxin toxicity is not often a dosing error. It is more often a patient whose situation changed underneath a dose that used to be correct.

Renal function is the usual hinge, since the drug is cleared by the kidneys and kidney function drifts with age, illness, and dehydration. Nothing on the medication record changes at all. What changed is the patient's ability to clear what is already prescribed.

Age matters for the same reason, and older adults are also the group whose early symptoms get attributed to something else entirely. Those two risks stacking in one person is why this drug stays on high-alert lists.

The visual changes are the part almost nothing else does

Digoxin has a signature very few drugs share. Patients describe yellow-tinged vision. Photophobia and reduced visual acuity are named beside it in the same reference.

So when a stem mentions someone on digoxin saying the room looks yellow, that detail is not scene-setting. It is the finding. Color complaints belong to a very short list of drugs, and this is the one they belong to.

What the rhythm actually shows

Two cardiac findings matter here, and they are different kinds of fact. Treating them as interchangeable is where points disappear.

Premature ventricular contractions are the most common cardiac finding in digoxin toxicity, per StatPearls. Common is not specific. Plenty of things produce PVCs, so seeing them should make you look harder rather than conclude.

Bidirectional ventricular tachycardia is the other one, and the same source calls it pathognomonic. That word earns its place. When it appears in a stem the diagnosis is settled, and the question is really asking what you do next.

A separate trap sits right beside this one. Digoxin also produces an expected ECG change during ordinary therapy that is not poisoning at all, and candidates lose points treating it as an emergency. That distinction has a post of its own.

Potassium is underneath all of it

Potassium and digoxin pull on each other in both directions, which changes the risk and changes how you read any level you are handed. That relationship is covered separately, because a single clause cannot carry it.

What comes before the antidote

Antibody fragments are the dramatic answer and they are rarely the first action an item is looking for.

Assess the patient first. Count an apical pulse for a full minute rather than glancing at a monitor, because rate is the parameter this drug moves and a quick check hides an irregular one. Withhold the dose and report rather than deciding alone.

Then gather what the team will need. A serum digoxin level, a potassium, and renal function, with continuous cardiac monitoring if the rhythm is unstable.

Options offering assessment and reporting usually beat options offering an antidote, unless the stem has already told you the patient is deteriorating in front of you.

The reversal agent, and how it gets dosed

The antidote is digoxin-specific antibody fragments, marketed as DigiFab or Digibind. They bind the drug itself rather than working against its effects downstream.

Dosing runs two ways, and knowing which is which is the exam-relevant part. When the serum level and the patient's weight are both known, the number of vials comes from a formula. When the level is unknown and the patient is deteriorating, StatPearls describes empiric dosing of 10 vials for an adult and 5 vials for a child.

Read what that second route implies. Treatment does not wait on a lab result. The level refines the dose; the patient decides that a dose is needed at all.

Levels carry a complication of their own, since two different therapeutic ranges still circulate in study material and they do not agree with each other. Which one to trust is sorted out in the levels post.

The shapes these items take

There are only a few. Recognizing which one you are in saves most of the time you would spend rereading.

The first hands you a cluster of vague symptoms in an older adult and expects you to notice the medication list. Poor appetite, nausea, and a bit of confusion are not a stomach bug when digoxin is on the chart.

The second gives you one striking detail, usually the vision complaint, and asks what it suggests. That is a recognition item and it is free if you carried the fact.

The third gives you a rhythm and asks what you do next. Here the difference between the common finding and the diagnostic one changes the answer, because one prompts assessment and the other prompts urgent action.

The fourth is a safety item. It puts a normal-looking level beside a low potassium and waits to see whether you read only the level.

How to hold this on exam day

Store the drug as a sequence rather than a list. The gut first. Then the vision. Then the rhythm.

That shape is what every high-alert drug rewards, one parameter you check and one event you are watching for, which is how the pillar post organizes the whole group.

And keep the two cardiac findings in separate boxes. PVCs mean look closer. Bidirectional ventricular tachycardia means you already know.

One last framing. This drug rarely fails loudly. It fails in details somebody wrote off, which is why a careful medication review counts as a clinical intervention rather than paperwork.